Transform the Treatment of Rheumatoid Arthritis
SetPoint Medical developed the SetPoint System, the first FDA-approved implantable device for treating rheumatoid arthritis through neuroimmune modulation — delivering daily one-minute electrical stimulation to the vagus nerve to activate the body's natural anti-inflammatory pathways. The miniaturized, rechargeable neurostimulator is clinically proven to reduce tender and swollen joint counts by an average of 60% over 12 months. The company is also studying the platform for multiple sclerosis and other autoimmune conditions.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountAug 2025
Aug 2025
Jan 2023
Create a free account to see which investors have funded this company.
Create Free Account
operates in the healthcare industry focusing on biotechnology business
Healthcare AI platform that converts patient-clinician conversations into structured clinical not...
OpenEvidence is an AI copilot for doctors that helps them make high stakes decisions at the point...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
